TACT
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
TACT On the Web |
|
American Roentgen Ray Society Images of TACT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Official Title
Trial to Assess Chelation Therapy (TACT)
Objective
The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
Sponsor
Mt. Sinai Medical Center, Miami
Timeline
| Timeline | |
| Start Date | September 2003 |
| Run-In Period | August 2012 |
| End Date | October 2011 |
| Status | Completed |
The previous information was derived from ClinicalTrials.gov on 11/19/2013 using the identification number NCT00044213.
Study Description
| Study Description | |
| Study Type | Interventional |
| Study Phase | Phase 3 |
| Study Design | |
| Allocation | Randomized |
| Endpoint | Efficacy Study |
| Interventional Model | Factorial Assignment |
| Masking | Double Blind (Subject, Investigator) |
| Study Details | |
| Primary Purpose | Treatment |
| Condition | Coronary artery disease |
| Intervention | EDTA <vs> EDTA placebo High dose vitamin High dose vitamin placebo |
| Study Arms | Active Comparator: EDTA + high dose vitamin Placebo Comparator: EDTA + high dose vitamin placebo Placebo Comparator: EDTA placebo + high dose vitamin Placebo Comparator: EDTA placebo + high dose vitamin placebo |
| Population Size | 1708 |
The previous information was derived from ClinicalTrials.gov on 11/19/2013 using the identification number NCT00044213.